Latest filing published 28 Oct 2025 for Tourmaline Bio, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Susan Dana Jones: trading record in brief
Susan Dana Jones is a declared insider of Talaris Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 19 October 2023 to 28 October 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 28 October 2025, the filings show a transaction in Talaris Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Susan Dana Jones
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,782 sharesCommon StockSEC:0001995339-25-000003:0
- 22,934 sharesCommon StockSEC:0001209191-23-053395:0
2 of 2 declarations